Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
84K characters. Original on sec.gov · Markdown
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
| (a) | 1. | FINANCIAL STATEMENTS | Page(s) | |||||||||||
| Included in Part II, Item 8. of this report: | ||||||||||||||
| Aflac Incorporated and Subsidiaries: | ||||||||||||||
| Report of Independent Registered Public Accounting Firm | 80 | |||||||||||||
| Consolidated Statements of Earnings for each of the years in the three- year period ended December 31, 2025 | 84 | |||||||||||||
| Consolidated Statements of Comprehensive Income (Loss) for each of the years in the three-year period ended December 31, 2025 | 85 | |||||||||||||
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | 86 | |||||||||||||
| Consolidated Statements of Shareholders' Equity for each of the years in the three-year period ended December 31, 2025 | 87 | |||||||||||||
| Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2025 | 89 | |||||||||||||
| Notes to the Consolidated Financial Statements | 90 | |||||||||||||
| 2. | FINANCIAL STATEMENT SCHEDULES | |||||||||||||
| Included in Part IV of this report: | ||||||||||||||
| Schedule II - | Condensed Financial Information of Registrant as of December 31, 2025 and 2024, and for each of the years in the three-year period ended December 31, 2025 | 197 | ||||||||||||
| Schedule III - | Supplementary Insurance Information as of December 31, 2025 and 2024, and for each of the years in the three-year period ended December 31, 2025 | 205 | ||||||||||||
| Schedule IV - | Reinsurance for each of the years in the three-year period ended December 31, 2025 | 206 | ||||||||||||
| 3. | EXHIBIT INDEX | |||||||||||||
| An “Exhibit Index” has been filed as part of this Report beginning on the following page and is incorporated herein by this reference. |
Schedules other than those listed above are omitted because they are not required, are not material, are not applicable, or the required information is shown in the financial statements or notes thereto.
In reviewing the agreements included as exhibits to this annual report, please remember they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:
-
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
-
have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
-
may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
-
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time.
| (b) | EXHIBIT INDEX*(1)* | |||||||||||||
| 3.0 | - | Articles of Incorporation, as amended – incorporated by reference from Form 10-Q for June 30, 2008, Exhibit 3.0. | ||||||||||||
| 3.1 | - | Bylaws of Aflac Incorporated, as amended and restated – incorporated by reference from Form 8-K dated November 17, 2023, Exhibit 3.1. | ||||||||||||
| 4.0 | - | There are no instruments with respect to long-term debt not being registered in which the total amount of securities authorized exceeds 10% of the total assets of Aflac Incorporated and its subsidiaries on a consolidated basis. The Company agrees to furnish a copy of any long-term debt instrument to the Securities and Exchange Commission upon request. | ||||||||||||
| 4.1 | - | Description of common stock securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 – incorporated by reference from 2019 Form 10-K, Exhibit 4.1. | ||||||||||||
| 4.2 | - | Indenture, dated as of May 21, 2009, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee – incorporated by reference from Form 8-K dated May 21, 2009, Exhibit 4.1. | ||||||||||||
| 4.3 | - | Second Supplemental Indenture, dated as of December 17, 2009, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 6.900% Senior Note due 2039) – incorporated by reference from Form 8-K dated December 14, 2009, Exhibit 4.1. | ||||||||||||
| 4.4 | - | Third Supplemental Indenture, dated as of August 9, 2010, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 6.45% Senior Note due 2040) – incorporated by reference from Form 8-K dated August 4, 2010, Exhibit 4.1. | ||||||||||||
| 4.5 | - | Twelfth Supplemental Indenture, dated as of September 19, 2016, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 2.875% Senior Note due 2026) – incorporated by reference from Form 8-K dated September 19, 2016, Exhibit 4.1. | ||||||||||||
| 4.6 | - | Thirteenth Supplemental Indenture, dated as of September 19, 2016, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 4.000% Senior Note due 2046) – incorporated by reference from Form 8-K dated September 19, 2016, Exhibit 4.2. | ||||||||||||
| 4.7 | - | Fourteenth Supplemental Indenture, dated as of January 25, 2017, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of .932% Senior Note due 2027) – incorporated by reference from Form 8-K dated January 25, 2017, Exhibit 4.1. | ||||||||||||
| 4.8 | - | Fifteenth Supplemental Indenture, dated as of October 18, 2018, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.159% Senior Note due 2030) – incorporated by reference from Form 8-K dated October 18, 2018, Exhibit 4.1. | ||||||||||||
| 4.9 | - | Sixteenth Supplemental Indenture, dated as of October 18, 2018, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.488% Senior Note due 2033) – incorporated by reference from Form 8-K dated October 18, 2018, Exhibit 4.2. | ||||||||||||
| 4.10 | - | Seventeenth Supplemental Indenture, dated as of October 18, 2018, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.750% Senior Note due 2038) – incorporated by reference from Form 8-K dated October 18, 2018, Exhibit 4.3. | ||||||||||||
| 4.11 | - | Eighteenth Supplemental Indenture, dated as of October 31, 2018, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 4.750% Senior Note due 2049) – incorporated by reference from Form 8-K dated October 31, 2018, Exhibit 4.1. | ||||||||||||
| 4.12 | - | Nineteenth Supplemental Indenture, dated as of December 17, 2019, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.500% Senior Note due 2029) – incorporated by reference from Form 8-K dated December 17, 2019, Exhibit 4.1. | ||||||||||||
| 4.13 | - | Twentieth Supplemental Indenture, dated as of December 17, 2019, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.843% Senior Note due 2031) – incorporated by reference from Form 8-K dated December 17, 2019, Exhibit 4.2. | ||||||||||||
| 4.14 | - | Twenty-First Supplemental Indenture, dated as of December 17, 2019, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.934% Senior Note due 2034) – incorporated by reference from Form 8-K dated December 17, 2019, Exhibit 4.3. | ||||||||||||
| 4.15 | - | Twenty-Second Supplemental Indenture, dated as of December 17, 2019, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.122% Senior Note due 2039) – incorporated by reference from Form 8-K dated December 17, 2019, Exhibit 4.4. | ||||||||||||
| 4.16 | - | Twenty-Third Supplemental Indenture, dated as of March 12, 2020, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.300% Senior Note due 2025) – incorporated by reference from Form 8-K dated March 12, 2020, Exhibit 4.1. |
| 4.17 | - | Twenty-Fourth Supplemental Indenture, dated as of March 12, 2020, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.550% Senior Note due 2030) – incorporated by reference from Form 8-K dated March 12, 2020, Exhibit 4.2. | ||||||||||||
| 4.18 | - | Twenty-Fifth Supplemental Indenture, dated as of March 12, 2020, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.750% Senior Note due 2032) – incorporated by reference from Form 8-K dated March 12, 2020, Exhibit 4.3. | ||||||||||||
| 4.19 | - | Twenty-Sixth Supplemental Indenture, dated as of March 12, 2020, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.830% Senior Note due 2035) – incorporated by reference from Form 8-K dated March 12, 2020, Exhibit 4.4. | ||||||||||||
| 4.20 | - | Twenty-Seventh Supplemental Indenture, dated as of April 1, 2020, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 3.600% Senior Note due 2030) – incorporated by reference from Form 8-K dated April 1, 2020, Exhibit 4.1. | ||||||||||||
| 4.21 | - | Twenty-Eighth Supplemental Indenture, dated as of March 8, 2021, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.125% Senior Sustainability Note due 2026) – incorporated by reference from Form 8-K dated March 8, 2021, Exhibit 4.1. | ||||||||||||
| 4.22 | - | Twenty-Ninth Supplemental Indenture, dated as of April 15, 2021, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.633% Senior Note due 2031) – incorporated by reference from Form 8-K dated April 15, 2021, Exhibit 4.1. | ||||||||||||
| 4.23 | - | Thirtieth Supplemental Indenture, dated as of April 15, 2021, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 0.844% Senior Note due 2033) – incorporated by reference from Form 8-K dated April 15, 2021, Exhibit 4.2. | ||||||||||||
| 4.24 | - | Thirty-First Supplemental Indenture, dated as of April 15, 2021, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.039% Senior Note due 2036) – incorporated by reference from Form 8-K dated April 15, 2021, Exhibit 4.3. | ||||||||||||
| 4.25 | - | Thirty-Second Supplemental Indenture, dated as of April 15, 2021, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.264% Senior Note due 2041) – incorporated by reference from Form 8-K dated April 15, 2021, Exhibit 4.4. | ||||||||||||
| 4.26 | - | Thirty-Third Supplemental Indenture, dated as of April 15, 2021, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.560% Senior Note due 2051) – incorporated by reference from Form 8-K dated April 15, 2021, Exhibit 4.5. | ||||||||||||
| 4.27 | - | Thirty-Fourth Supplemental Indenture, dated as of September 14, 2022, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.075% Senior Note due 2029) – incorporated by reference from Form 8-K dated September 14, 2022, Exhibit 4.1. | ||||||||||||
| 4.28 | - | Thirty-Fifth Supplemental Indenture, dated as of September 14, 2022, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.320% Senior Note due 2032) – incorporated by reference from Form 8-K dated September 14, 2022, Exhibit 4.2. | ||||||||||||
| 4.29 | - | Thirty-Sixth Supplemental Indenture, dated as of September 14, 2022, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.594% Senior Note due 2037) – incorporated by reference from Form 8-K dated September 14, 2022, Exhibit 4.3. | ||||||||||||
| 4.30 | - | Thirty-Seventh Supplemental Indenture, dated as of September 14, 2022, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 2.144% Senior Note due 2052) – incorporated by reference from Form 8-K dated September 14, 2022, Exhibit 4.4. | ||||||||||||
| 4.31 | - | Thirty-Eighth Supplemental Indenture, dated as of March 21, 2024, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.048% Senior Note due 2029) – incorporated by reference from Form 8-K dated March 21, 2024, Exhibit 4.1. | ||||||||||||
| 4.32 | - | Thirty-Ninth Supplemental Indenture, dated as of March 21, 2024, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.412% Senior Note due 2031) – incorporated by reference from Form 8-K dated March 21, 2024, Exhibit 4.2. | ||||||||||||
| 4.33 | - | Fortieth Supplemental Indenture, dated as of March 21, 2024, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.682% Senior Note due 2034) – incorporated by reference from Form 8-K dated March 21, 2024, Exhibit 4.3. | ||||||||||||
| 4.34 | - | Forty-First Supplemental Indenture, dated as of June 5, 2025, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 1.726% Senior Note due 2030) – incorporated by reference from Form 8-K dated June 5, 2025, Exhibit 4.1. | ||||||||||||
| 4.35 | - | Forty-Second Supplemental Indenture, dated as of June 5, 2025, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 2.003% Senior Note due 2032) – incorporated by reference from Form 8-K dated June 5, 2025, Exhibit 4.2. |
| 4.36 | - | Forty-Third Supplemental Indenture, dated as of June 5, 2025, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 2.369% Senior Note due 2035) – incorporated by reference from Form 8-K dated June 5, 2025, Exhibit 4.3. | ||||||||||||
| 4.37 | - | Forty-Fourth Supplemental Indenture, dated as of June 5, 2025, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 2.779% Senior Note due 2040) – incorporated by reference from Form 8-K dated June 5, 2025, Exhibit 4.4. | ||||||||||||
| 4.38 | - | Subordinated Indenture, dated as of September 26, 2012, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee – incorporated by reference from Form 8-K dated September 26, 2012, Exhibit 4.1. | ||||||||||||
| 4.39 | - | Second Supplemental Indenture, dated as of October 23, 2017, between Aflac Incorporated and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 2.108% Subordinated Debenture due 2047) - incorporated by reference from Form 8-K dated October 23, 2017, Exhibit 4.1. | ||||||||||||
| 10.0* | - | American Family Corporation Retirement Plan for Senior Officers, as amended and restated October 1, 1989 – incorporated by reference from 1993 Form 10-K, Exhibit 10.2. | ||||||||||||
| 10.1* | - | Amendment to American Family Corporation Retirement Plan for Senior Officers, dated December 8, 2008 – incorporated by reference from 2008 Form 10-K, Exhibit 10.1. | ||||||||||||
| 10.2* | - | Second Amendment to the American Family Corporation Retirement Plan for Senior Officers, dated November 16, 2012 – incorporated by reference from Form 10-Q for September 30, 2016, Exhibit 10.2. | ||||||||||||
| 10.3* | - | Third Amendment to the American Family Corporation Retirement Plan for Senior Officers, dated October 18, 2016 – incorporated by reference from Form 10-Q for September 30, 2016, Exhibit 10.3. | ||||||||||||
| 10.4* | - | Fourth Amendment to the American Family Corporation Retirement Plan for Senior Officers – incorporated by reference from Form 8-K dated June 13, 2023, Exhibit 10.2. | ||||||||||||
| 10.5* | - | Aflac Incorporated Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2009 – incorporated by reference from 2008 Form 10-K, Exhibit 10.5. | ||||||||||||
| 10.6* | - | First Amendment to the Aflac Incorporated Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2009 – incorporated by reference from 2012 Form 10-K, Exhibit 10.3. | ||||||||||||
| 10.7* | - | Second Amendment to the Aflac Incorporated Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2009 – incorporated by reference from 2014 Form 10-K, Exhibit 10.4. | ||||||||||||
| 10.8* | - | Third Amendment to the Aflac Incorporated Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2009 – incorporated by reference from Form 8-K dated June 13, 2023, Exhibit 10.1. | ||||||||||||
| 10.9* | - | Aflac Incorporated Executive Deferred Compensation Plan, as amended and restated, effective January 1, 2020 – incorporated by reference from 2019 Form 10-K, Exhibit 10.11. | ||||||||||||
| 10.10* | - | First Amendment to the Aflac Incorporated Executive Deferred Compensation Plan, as amended and restated, effective January 1, 2020 – incorporated by reference from Form 10-Q for June 30, 2020, Exhibit 10.1. | ||||||||||||
| 10.11* | - | Second Amendment to the Aflac Incorporated Executive Deferred Compensation Plan, as amended and restated, effective January 1, 2020 – incorporated by reference from Form 10-Q for September 30, 2022, Exhibit 10.1. | ||||||||||||
| 10.12* | - | Aflac Incorporated 2018 Management Incentive Plan – incorporated by reference from the 2017 Proxy Statement, Appendix B. | ||||||||||||
| 10.13* | - | Aflac Incorporated 2023 Management Incentive Plan – incorporated by reference from Form 8-K dated February 10, 2023, Exhibit 10.1. | ||||||||||||
| 10.14* | - | 1999 Aflac Associate Stock Bonus Plan, amended and restated as of February 1, 2021 – incorporated by reference from Form 10-Q for March 31, 2021, Exhibit 10.1. | ||||||||||||
| 10.15* | - | 2004 Aflac Incorporated Long-Term Incentive Plan, as amended and restated March 14, 2012 – incorporated by reference from the 2012 Proxy Statement, Appendix A. | ||||||||||||
| 10.16* | - | Form of Non-Employee Director Stock Option Agreement (NQSO) under the 2004 Aflac Incorporated Long-Term Incentive Plan, as amended and restated March 14, 2012 – incorporated by reference from Form 10-Q for March 31, 2016, Exhibit 10.13. | ||||||||||||
| 10.17* | - | U.S. Form of Employee Stock Option Agreement (Non-Qualifying Stock Option) under the 2004 Aflac Incorporated Long-Term Incentive Plan, as amended and restated March 14, 2012 – incorporated by reference from Form 10-Q for March 31, 2016, Exhibit 10.21. | ||||||||||||
| 10.18* | - | Japan Form of Employee Stock Option Agreement (Non-Qualifying Stock Option) under the 2004 Aflac Incorporated Long-Term Incentive Plan, as amended and restated March 14, 2012 – incorporated by reference from Form 10-Q for March 31, 2016, Exhibit 10.22. |
| 10.19* | - | U.S. Form of Employee Stock Option Agreement (Incentive Stock Option) under the 2004 Aflac Incorporated Long-Term Incentive Plan, as amended and restated March 14, 2012 – incorporated by reference from Form 10-Q for March 31, 2016, Exhibit 10.23. | ||||||||||||
| 10.20* | - | Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017 – incorporated by reference from Form 8-K dated May 1, 2017, Exhibit 10.1. | ||||||||||||
| 10.21* | - | First Amendment to the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017 – incorporated by reference from Form 10-Q for September 30, 2022, Exhibit 10.2. | ||||||||||||
| 10.22* | - | Form of Non-Employee Director Stock Option Agreement (Non-Qualifying Stock Option) under the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017 – incorporated by reference from Form 10-Q for June 30, 2017, Exhibit 10.33. | ||||||||||||
| 10.23* | - | Form of Non-Employee Director Restricted Stock Award Agreement under the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017 – incorporated by reference from Form 10-Q for June 30, 2017, Exhibit 10.34. | ||||||||||||
| 10.24* | - | U.S. Form of Employee Restricted Stock Award Agreement under the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017 – incorporated by reference from Form 8-K dated February 11, 2022, Exhibit 10.1. | ||||||||||||
| 10.25* | - | Japan Form of Employee Restricted Stock Award Agreement under the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017 – incorporated by reference from Form 8-K dated February 11, 2022, Exhibit 10.2. | ||||||||||||
| 10.26* | - | U.S. Form of Employee Restricted Stock Unit Award Agreement under the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017. | ||||||||||||
| 10.27* | - | Japan Form of Employee Restricted Stock Unit Award Agreement under the Aflac Incorporated Long-Term Incentive Plan, as amended and restated February 14, 2017. | ||||||||||||
| 10.28* | - | Aflac Incorporated Retirement Plan for Directors Emeritus, as amended and restated, dated February 9, 2010 – incorporated by reference from 2009 Form 10-K, Exhibit 10.26. | ||||||||||||
| 10.29* | - | Amendment to Aflac Incorporated Retirement Plan for Directors Emeritus, as amended and restated, dated August 10, 2010 – incorporated by reference from Form 10-Q for September 30, 2010, Exhibit 10.27. | ||||||||||||
| 10.30* | - | Aflac Life Insurance Japan Ltd. Officer Retirement Plan – incorporated by reference from 2019 Form 10-K, Exhibit 10.43. | ||||||||||||
| 10.31* | - | Aflac Incorporated Executive Officer Severance Plan – incorporated by reference from Form 10-Q for March 31, 2023, Exhibit 10.2. | ||||||||||||
| 10.32* | - | Aflac Incorporated Employment Agreement with Daniel P. Amos, as amended and restated, dated August 20, 2015 – incorporated by reference from Form 10-Q for September 30, 2015, Exhibit 10.29. | ||||||||||||
| 10.33* | - | Aflac Incorporated Employment Agreement with Audrey Boone Tillman, dated June 11, 2015 – incorporated by reference from Form 10-Q for March 31, 2018, Exhibit 10.6. | ||||||||||||
| 10.34* | - | Amendment to Aflac Incorporated Employment Agreement with Audrey Boone Tillman, dated October 24, 2022 – incorporated by reference from 2022 Form 10-K, Exhibit 10.34. | ||||||||||||
| 10.35* | - | Amendment to Aflac Incorporated Employment Agreement with Audrey Boone Tillman, dated November 1, 2024 – incorporated by reference from 2024 Form 10-K, Exhibit 10.33. | ||||||||||||
| 10.36* | - | Aflac Incorporated Employment Agreement with Max K. Brodén, dated April 29, 2021 – incorporated by reference from Form 10-Q for March 31, 2021, Exhibit 10.3. | ||||||||||||
| 10.37* | - | Amendment to Aflac Incorporated Employment Agreement with Max K. Brodén, dated October 24, 2022 – incorporated by reference from 2022 Form 10-K, Exhibit 10.37. | ||||||||||||
| 10.38* | - | Amendment to Aflac Incorporated Employment Agreement with Max K. Brodén, dated November 1, 2024 – incorporated by reference from 2024 Form 10-K, Exhibit 10.36. | ||||||||||||
| 10.39 | - | Agency Services Agreement, dated March 1, 2008, by and between Japan Post Network Co., Ltd. and Aflac – incorporated by reference from Form 10-Q for March 31, 2020, Exhibit 10.2. | ||||||||||||
| 10.40** | - | Amendment Agreement to Agency Services Agreement, dated June 27, 2016, by and between Japan Post Co., Ltd. and Aflac – incorporated by reference from Form 10-Q for March 31, 2020, Exhibit 10.3. | ||||||||||||
| 10.41 | - | Basic Agreement regarding the “Strategic Alliance Based on Capital Relationship”, dated December 19, 2018, by and among Japan Post Holdings Co., Ltd., Aflac Incorporated and Aflac Life Insurance Japan Ltd. – incorporated by reference from Form 8-K dated December 19, 2018, Exhibit 10.1. | ||||||||||||
| 10.42 | - | Letter Agreement, dated December 19, 2018, by and between Japan Post Holdings Co., Ltd. and Aflac Incorporated – incorporated by reference from Form 8-K dated December 19, 2018, Exhibit 10.2. |
| 10.43 | - | Shareholders Agreement, dated February 28, 2019, by and between Aflac Incorporated, Japan Post Holdings Co., Ltd., J&A Alliance Holdings Corporation (solely in its capacity as trustee of J&A Alliance Trust), and General Incorporated Association J&A Alliance – incorporated by reference from Form 10-Q for March 31, 2019, Exhibit 10.50. | ||||||||||||
| 19*** | - | Aflac Incorporated's Insider Trading Policy and Compliance Procedures – incorporated by reference from 2024 Form 10-K, Exhibit 19. | ||||||||||||
| 21 | - | Subsidiaries. | ||||||||||||
| 23 | - | Consent of independent registered public accounting firm, KPMG LLP, to Form S-8 Registration Statement No. 333-158969 with respect to the Aflac Incorporated 401(k) Savings and Profit Sharing Plan. | ||||||||||||
| - | Consent of independent registered public accounting firm, KPMG LLP, to Form S-8 Registration Statement Nos. 333-135327, 333-161269, 333-202781, 333-245702, and 333-293458 with respect to the Aflac Incorporated Executive Deferred Compensation Plan. | |||||||||||||
| - | Consent of independent registered public accounting firm, KPMG LLP, to Form S-8 Registration Statement No. 333-115105 and 333-219888 with respect to the Aflac Incorporated Long-Term Incentive Plan. | |||||||||||||
| - | Consent of independent registered public accounting firm, KPMG LLP, to Form S-3 Registration Statement No. 333-273722 with respect to the AFL Stock Plan. | |||||||||||||
| - | Consent of independent registered public accounting firm, KPMG LLP, to Form S-3 Registration Statement No. 333-271561 with respect to the resale of Aflac Incorporated common stock by J&A Alliance Holdings Corporation in its capacity as the trustee of J&A Alliance Trust. | |||||||||||||
| - | Consent of independent registered public accounting firm, KPMG LLP, to Form S-3 Registration Statement No. 333-281977 with respect to the Aflac Incorporated shelf registration statement. | |||||||||||||
| 31.1 | - | Certification of CEO dated February 25, 2026, required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934. | ||||||||||||
| 31.2 | - | Certification of CFO dated February 25, 2026, required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934. | ||||||||||||
| 32 | - | Certification of CEO and CFO dated February 25, 2026, pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||||
| 97* | - | Aflac Incorporated Policy on Recoupment of Incentive Compensation, as amended. | ||||||||||||
| 101.INS | - | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||||
| 101.SCH | - | Inline XBRL Taxonomy Extension Schema. | ||||||||||||
| 101.CAL | - | Inline XBRL Taxonomy Extension Calculation Linkbase. | ||||||||||||
| 101.DEF | - | Inline XBRL Taxonomy Extension Definition Linkbase. | ||||||||||||
| 101.LAB | - | Inline XBRL Taxonomy Extension Label Linkbase. | ||||||||||||
| 101.PRE | - | Inline XBRL Taxonomy Extension Presentation Linkbase. | ||||||||||||
| 104 | - | Cover Page Interactive Data File - formatted as Inline XBRL and contained in Exhibit 101. | ||||||||||||
| (1) | Copies of any exhibit are available upon request by calling the Company's Investor Relations Department at 800.235.2667 - option 3 | |||||||||||||
| * | Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15(b) of this report. | |||||||||||||
| ** | Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10). | |||||||||||||
| *** | Portions of this exhibit have been redacted. |
| (c) | FINANCIAL STATEMENT SCHEDULES |
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
Aflac Incorporated (Parent Only)
Condensed Statements of Earnings
| Years ended December 31, | |||||||||||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||||||||||||||
| Management and service fees from subsidiaries*(1)* | $ | 170 | $ | 163 | $ | 151 | |||||||||||||||||||||||||||||
| Net investment income | 147 | 31 | (174) | ||||||||||||||||||||||||||||||||
| Interest from subsidiaries*(1)* | 1 | 1 | 1 | ||||||||||||||||||||||||||||||||
| Net investment gains (losses) | 122 | 503 | 301 | ||||||||||||||||||||||||||||||||
| Total revenues | 440 | 698 | 279 | ||||||||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||
| Interest expense | 213 | 189 | 187 | ||||||||||||||||||||||||||||||||
| Other operating expenses | 392 | 282 | 295 | ||||||||||||||||||||||||||||||||
| Total operating expenses | 605 | 471 | 482 | ||||||||||||||||||||||||||||||||
| Earnings before income taxes and equity in earnings of subsidiaries | (165) | 227 | (203) | ||||||||||||||||||||||||||||||||
| Income tax expense (benefit) | (103) | (126) | (444) | ||||||||||||||||||||||||||||||||
| Earnings before equity in earnings of subsidiaries | (62) | 353 | 241 | ||||||||||||||||||||||||||||||||
| Equity in earnings of subsidiaries*(1)* | 3,708 | 5,090 | 4,418 | ||||||||||||||||||||||||||||||||
| Net earnings | $ | 3,646 | $ | 5,443 | $ | 4,659 |
*(1)*Eliminated in consolidation
See the accompanying Notes to Condensed Financial Statements.
See the accompanying Report of Independent Registered Public Accounting Firm.
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
Aflac Incorporated (Parent Only)
Condensed Statements of Comprehensive Income (Loss)
| Years ended December 31, | |||||||||||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| Net earnings | $ | 3,646 | $ | 5,443 | $ | 4,659 | |||||||||||||||||||||||||||||
| Other comprehensive income (loss) before income taxes: | |||||||||||||||||||||||||||||||||||
| Unrealized foreign currency translation gains (losses) during period | 146 | (769) | (366) | ||||||||||||||||||||||||||||||||
| Unrealized gains (losses) on fixed maturity securities during period | (2,322) | (1,421) | 2,327 | ||||||||||||||||||||||||||||||||
| Unrealized gains (losses) on derivatives during period | 8 | 3 | 6 | ||||||||||||||||||||||||||||||||
| Effect of changes in discount rate assumptions during period | 7,631 | 5,780 | (582) | ||||||||||||||||||||||||||||||||
| Pension liability adjustment during period | 97 | 23 | 35 | ||||||||||||||||||||||||||||||||
| Total other comprehensive income (loss) before income taxes | 5,560 | 3,616 | 1,420 | ||||||||||||||||||||||||||||||||
| Income tax expense (benefit) related to items of other comprehensive income (loss) | 1,130 | 1,074 | 511 | ||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of income taxes | 4,430 | 2,542 | 909 | ||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | $ | 8,076 | $ | 7,985 | $ | 5,568 |
See the accompanying Notes to Condensed Financial Statements.
See the accompanying Report of Independent Registered Public Accounting Firm.
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
Aflac Incorporated (Parent Only)
Condensed Balance Sheets
| December 31, | |||||||||||||||||||||||
| (In millions, except for share and per-share amounts) | 2025 | 2024 | |||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Investments and cash: | |||||||||||||||||||||||
| Fixed maturity securities available-for-sale, at fair value (no allowance for credit losses in 2025 and 2024, amortized cost $1,728 in 2025 and $1,702 in 2024) | $ | 1,714 | $ | 1,713 | |||||||||||||||||||
| Investments in subsidiaries*(1)* | 32,215 | 27,890 | |||||||||||||||||||||
| Other investments | 978 | 1,239 | |||||||||||||||||||||
| Cash and cash equivalents | 2,646 | 2,308 | |||||||||||||||||||||
| Total investments and cash | 37,553 | 33,150 | |||||||||||||||||||||
| Due from subsidiaries*(1)* | 206 | 242 | |||||||||||||||||||||
| Income taxes receivable | 147 | 71 | |||||||||||||||||||||
| Other assets | 946 | 1,121 | |||||||||||||||||||||
| Total assets | $ | 38,852 | $ | 34,584 | |||||||||||||||||||
| Liabilities and shareholders' equity: | |||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Employee benefit plans | $ | 357 | $ | 347 | |||||||||||||||||||
| Notes payable and lease obligations | 8,143 | 7,219 | |||||||||||||||||||||
| Other liabilities | 862 | 920 | |||||||||||||||||||||
| Total liabilities | 9,362 | 8,486 | |||||||||||||||||||||
| Shareholders' equity: | |||||||||||||||||||||||
| Common stock of $.10 par value. In thousands: authorized 1,900,000 shares in 2025 and 2024; issued 1,357,909 shares in 2025 and 1,356,763 shares in 2024 | 136 | 136 | |||||||||||||||||||||
| Additional paid-in capital | 3,024 | 2,894 | |||||||||||||||||||||
| Retained earnings | 54,682 | 52,277 | |||||||||||||||||||||
| Accumulated other comprehensive income (loss): | |||||||||||||||||||||||
| Unrealized foreign currency translation gains (losses) | (4,847) | (4,998) | |||||||||||||||||||||
| Unrealized gains (losses) on fixed maturity securities | (1,809) | 24 | |||||||||||||||||||||
| Unrealized gains (losses) on derivatives | (13) | (20) | |||||||||||||||||||||
| Effect of changes in discount rate assumptions | 8,035 | 2,006 | |||||||||||||||||||||
| Pension liability adjustment | 86 | 10 | |||||||||||||||||||||
| Treasury stock, at average cost | (29,804) | (26,231) | |||||||||||||||||||||
| Total shareholders' equity | 29,490 | 26,098 | |||||||||||||||||||||
| Total liabilities and shareholders' equity | $ | 38,852 | $ | 34,584 |
*(1)*Eliminated in consolidation
See the accompanying Notes to Condensed Financial Statements.
See the accompanying Report of Independent Registered Public Accounting Firm.
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
Aflac Incorporated (Parent Only)
Condensed Statements of Cash Flows
| Years ended December 31, | |||||||||||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||||||||||||||||||||
| Net earnings | $ | 3,646 | $ | 5,443 | $ | 4,659 | |||||||||||||||||||||||||||||
| Adjustments to reconcile net earnings to net cash provided from operating activities: | |||||||||||||||||||||||||||||||||||
| Equity in earnings of subsidiaries*(1)* | (3,708) | (5,090) | (4,418) | ||||||||||||||||||||||||||||||||
| Cash dividends received from subsidiaries | 3,824 | 4,274 | 3,410 | ||||||||||||||||||||||||||||||||
| Other, net | (52) | (292) | (686) | ||||||||||||||||||||||||||||||||
| Net cash provided (used) by operating activities | 3,710 | 4,335 | 2,965 | ||||||||||||||||||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities sold | 824 | 572 | 547 | ||||||||||||||||||||||||||||||||
| Fixed maturity securities purchased | (772) | (695) | (345) | ||||||||||||||||||||||||||||||||
| Other investments sold (purchased) | 125 | (243) | (34) | ||||||||||||||||||||||||||||||||
| Settlement of derivatives | 277 | 469 | 693 | ||||||||||||||||||||||||||||||||
| Additional capitalization of subsidiaries*(1)* | (15) | (84) | (203) | ||||||||||||||||||||||||||||||||
| Other, net | (58) | 0 | 1 | ||||||||||||||||||||||||||||||||
| Net cash provided (used) by investing activities | 381 | 19 | 659 | ||||||||||||||||||||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||||||||||||||||||||
| Purchases of treasury stock | (3,530) | (2,800) | (2,801) | ||||||||||||||||||||||||||||||||
| Proceeds from borrowings | 1,039 | 823 | 0 | ||||||||||||||||||||||||||||||||
| Principal payments under debt obligations | (84) | 0 | 0 | ||||||||||||||||||||||||||||||||
| Dividends paid to shareholders | (1,198) | (1,087) | (966) | ||||||||||||||||||||||||||||||||
| Treasury stock reissued | 8 | 14 | 17 | ||||||||||||||||||||||||||||||||
| Proceeds from exercise of stock options | 7 | 9 | 13 | ||||||||||||||||||||||||||||||||
| Net change in amount due to/from subsidiaries*(1)* | 25 | (5) | (6) | ||||||||||||||||||||||||||||||||
| Other, net | (20) | (7) | (17) | ||||||||||||||||||||||||||||||||
| Net cash provided (used) by financing activities | (3,753) | (3,053) | (3,760) | ||||||||||||||||||||||||||||||||
| Net change in cash and cash equivalents | 338 | 1,301 | (136) | ||||||||||||||||||||||||||||||||
| Cash and cash equivalents, beginning of period | 2,308 | 1,007 | 1,143 | ||||||||||||||||||||||||||||||||
| Cash and cash equivalents, end of period | $ | 2,646 | $ | 2,308 | $ | 1,007 |
(1) Eliminated in consolidation
See the accompanying Notes to Condensed Financial Statements.
See the accompanying Report of Independent Registered Public Accounting Firm.
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
Aflac Incorporated (Parent Only)
Notes to Condensed Financial Statements
The accompanying condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto of Aflac Incorporated and Subsidiaries included in Part II, Item 8. of this report.
(A) Notes Payable and Lease Obligations
A summary of notes payable and lease obligations as of December 31 follows:
| (In millions) | 2025 | 2024 | |||||||||||||||||||||
| 1.125% senior sustainability notes due March 2026 | $ | 400 | $ | 399 | |||||||||||||||||||
| 2.875% senior notes due October 2026 | 299 | 299 | |||||||||||||||||||||
| 3.60% senior notes due April 2030 | 995 | 994 | |||||||||||||||||||||
| 6.90% senior notes due December 2039 | 221 | 221 | |||||||||||||||||||||
| 6.45% senior notes due August 2040 | 255 | 255 | |||||||||||||||||||||
| 4.00% senior notes due October 2046 | 394 | 394 | |||||||||||||||||||||
| 4.750% senior notes due January 2049 | 542 | 542 | |||||||||||||||||||||
| Yen-denominated senior notes and subordinated debentures: | |||||||||||||||||||||||
| .300% senior notes paid September 2025 (principal amount ¥12.4 billion) | 0 | 79 | |||||||||||||||||||||
| .932% senior notes due January 2027 (principal amount ¥60.0 billion) | 382 | 378 | |||||||||||||||||||||
| 1.048% senior notes due March 2029 (principal amount ¥13.0 billion) | 83 | 81 | |||||||||||||||||||||
| 1.075% senior notes due September 2029 (principal amount ¥33.4 billion) | 213 | 211 | |||||||||||||||||||||
| .500% senior notes due December 2029 (principal amount ¥12.6 billion) | 80 | 79 | |||||||||||||||||||||
| .550% senior notes due March 2030 (principal amount ¥13.3 billion) | 85 | 84 | |||||||||||||||||||||
| 1.159% senior notes due October 2030 (principal amount ¥29.3 billion) | 186 | 184 | |||||||||||||||||||||
| 1.726% senior notes due October 2030 (principal amount ¥35.0 billion) | 223 | 0 | |||||||||||||||||||||
| 1.412% senior notes due March 2031 (principal amount ¥27.9 billion) | 178 | 176 | |||||||||||||||||||||
| .633% senior notes due April 2031 (principal amount ¥30.0 billion) | 191 | 189 | |||||||||||||||||||||
| .843% senior notes due December 2031 (principal amount ¥9.3 billion) | 59 | 58 | |||||||||||||||||||||
| .750% senior notes due March 2032 (principal amount ¥20.7 billion) | 131 | 130 | |||||||||||||||||||||
| 1.990% senior notes due May 2032 (principal amount ¥18.2 billion) | 116 | 0 | |||||||||||||||||||||
| 1.320% senior notes due December 2032 (principal amount ¥21.1 billion) | 134 | 133 | |||||||||||||||||||||
| 2.003% senior notes due December 2032 (principal amount ¥23.4 billion) | 149 | 0 | |||||||||||||||||||||
| .844% senior notes due April 2033 (principal amount ¥12.0 billion) | 76 | 76 | |||||||||||||||||||||
| 1.488% senior notes due October 2033 (principal amount ¥15.2 billion) | 97 | 95 | |||||||||||||||||||||
| 1.682% senior notes due March 2034 (principal amount ¥7.7 billion) | 49 | 48 | |||||||||||||||||||||
| 1.600% senior notes due March 2034 (principal amount ¥18.3 billion) | 116 | 115 | |||||||||||||||||||||
| .934% senior notes due December 2034 (principal amount ¥9.8 billion) | 62 | 62 | |||||||||||||||||||||
| .830% senior notes due March 2035 (principal amount ¥10.6 billion) | 67 | 66 | |||||||||||||||||||||
| 2.320% senior notes due May 2035 (principal amount ¥38.3 billion) | 245 | 0 | |||||||||||||||||||||
| 2.369% senior notes due June 2035 (principal amount ¥9.5 billion) | 60 | 0 | |||||||||||||||||||||
| 1.740% senior notes due March 2036 (principal amount ¥15.0 billion) | 95 | 94 | |||||||||||||||||||||
| 1.039% senior notes due April 2036 (principal amount ¥10.0 billion) | 64 | 63 | |||||||||||||||||||||
| 1.594% senior notes due September 2037 (principal amount ¥6.5 billion) | 41 | 41 | |||||||||||||||||||||
| 1.750% senior notes due October 2038 (principal amount ¥8.9 billion) | 56 | 56 | |||||||||||||||||||||
| 1.920% senior notes due March 2039 (principal amount ¥16.5 billion) | 104 | 103 | |||||||||||||||||||||
| 1.122% senior notes due December 2039 (principal amount ¥6.3 billion) | 40 | 39 | |||||||||||||||||||||
| 2.650% senior notes due May 2040 (principal amount ¥11.6 billion) | 74 | 0 | |||||||||||||||||||||
| 2.779% senior notes due June 2040 (principal amount ¥7.0 billion) | 45 | 0 | |||||||||||||||||||||
| 1.264% senior notes due April 2041 (principal amount ¥10.0 billion) | 63 | 63 | |||||||||||||||||||||
| 2.160% senior notes due March 2044 (principal amount ¥5.7 billion) | 36 | 35 | |||||||||||||||||||||
| 3.040% senior notes due May 2045 (principal amount ¥7.0 billion) | 45 | 0 | |||||||||||||||||||||
| 2.108% subordinated debentures due October 2047 (principal amount ¥60.0 billion) | 379 | 375 | |||||||||||||||||||||
| 1.560% senior notes due April 2051 (principal amount ¥20.0 billion) | 127 | 125 | |||||||||||||||||||||
| 2.144% senior notes due September 2052 (principal amount ¥12.0 billion) | 76 | 75 | |||||||||||||||||||||
| 2.400% senior notes due March 2054 (principal amount ¥19.5 billion) | 124 | 122 | |||||||||||||||||||||
| Yen-denominated loans: | |||||||||||||||||||||||
| Variable interest rate loan due August 2027 (1.08% in 2025 and .84% in 2024, principal amount ¥11.7 billion) | 75 | 74 | |||||||||||||||||||||
| Variable interest rate loan due August 2029 (1.18% in 2025 and .94% in 2024, principal amount ¥25.3 billion) | 161 | 160 | |||||||||||||||||||||
| Variable interest rate loan due August 2032 (1.33% in 2025 and 1.09% in 2024, principal amount ¥70.0 billion) | 446 | 441 | |||||||||||||||||||||
| Operating lease obligations payable through 2032 | 4 | 5 | |||||||||||||||||||||
| Total notes payable and lease obligations | $ | 8,143 | $ | 7,219 |
Amounts in the table above are reported net of debt issuance costs and issuance premiums or discounts, if applicable, that are being amortized over the life of the notes.
In September 2025, the Parent Company extinguished ¥12.4 billion of .300% senior notes upon their maturity.
In June 2025, the Parent Company issued four series of senior notes totaling ¥74.9 billion through a public debt offering under its U.S. shelf registration statement. The first series, which totaled ¥35.0 billion, bears interest at a fixed rate of 1.726% per annum, payable semiannually, and will mature in October 2030. The second series, which totaled ¥23.4 billion, bears interest at a fixed rate of 2.003% per annum, payable semiannually, and will mature in December 2032. The third series, which totaled ¥9.5 billion, bears interest at a fixed rate of 2.369% per annum, payable semiannually, and will mature in June 2035. The fourth series, which totaled ¥7.0 billion, bears interest at a fixed rate of 2.779% per annum, payable semiannually, and will mature in June 2040. These notes are redeemable at the Parent Company’s option at any time, in whole but not in part, upon the occurrence of certain changes affecting U.S. taxation, as specified in the indenture governing the terms of the issuance. In addition, the notes maturing in October 2030, December 2032, June 2035 and June 2040 are redeemable at the Parent Company's option, in whole or in part from time to time, on or after July 18, 2030, September 14, 2032, December 5, 2034, and December 5, 2039, respectively, at a redemption price equal to the aggregate principal amount of the applicable series to be redeemed plus accrued and unpaid interest on the principal amount to be redeemed to, but excluding, the date of redemption.
In May 2025, the Parent Company issued four series of senior notes totaling ¥75.1 billion through a private placement. The first series, which totaled ¥18.2 billion, bears interest at a fixed rate of 1.990% per annum, payable semiannually, and will mature in May 2032. The second series, which totaled ¥38.3 billion, bears interest at a fixed rate of 2.320% per annum, payable semiannually, and will mature in May 2035. The third series, which totaled ¥11.6 billion, bears interest at a fixed rate of 2.650% per annum, payable semiannually, and will mature in May 2040. The fourth series, which totaled ¥7.0 billion, bears interest at a fixed rate of 3.040% per annum, payable semiannually, and will mature in May 2045. These notes are redeemable at the Parent Company's option (i) in whole at any time or (ii) in part from time to time in an amount not less than 5% of the aggregate principal amount then outstanding of the notes to be redeemed.
The aggregate contractual maturities of notes payable during each of the years after December 31, 2025, are as follows:
| (In millions) | ||||||||
| 2026 | $ | 700 | ||||||
| 2027 | 458 | |||||||
| 2028 | 0 | |||||||
| 2029 | 539 | |||||||
| 2030 | 1,496 | |||||||
| Thereafter | 4,994 | |||||||
| Total | $ | 8,187 |
For further information regarding notes payable and lease obligations, see Note 9 of the Notes to the Consolidated Financial Statements.
(B) Derivatives
At December 31, 2025, the Parent Company's outstanding freestanding derivative contracts were foreign currency forwards. The foreign currency forwards are designated as derivative hedges of the foreign currency exposure of the Company's net investment in Aflac Japan. The Parent Company also enters into foreign currency forward contracts with Aflac Re to economically manage the currency mismatch between Aflac Re's assets which are mostly denominated in U.S. dollars and its liabilities which are mostly denominated in Japanese yen. The Parent Company does not use derivative financial instruments for trading purposes, nor does it engage in leveraged derivative transactions. For further information regarding these derivatives, see Notes 1 and 4 of the Notes to the Consolidated Financial Statements.
(C) Income Taxes
The Parent Company and its eligible U.S. subsidiaries file a consolidated U.S. federal income tax return. Income tax liabilities or benefits are recorded by each principal subsidiary based upon separate return calculations, and any difference between the consolidated provision and the aggregate amounts recorded by the subsidiaries is reflected in the Parent Company financial statements. For further information on income taxes, see Note 10 of the Notes to the Consolidated Financial Statements.
(D) Dividend Restrictions
See Note 14 of the Notes to the Consolidated Financial Statements for information regarding dividend restrictions.
(E) Supplemental Disclosures of Cash Flow Information
| (In millions) | 2025 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| Interest paid | $ | 197 | $ | 180 | $ | 184 | |||||||||||||||||||||||||||||
| Noncash financing activities: | |||||||||||||||||||||||||||||||||||
| Treasury stock issued for shareholder dividend reinvestment | 43 | 41 | 37 |
SCHEDULE III
SUPPLEMENTARY INSURANCE INFORMATION
Aflac Incorporated and Subsidiaries
Years ended December 31,
| (In millions) | Deferred Policy Acquisition Costs | Future Policy Benefits & Unpaid Policy Claims | Unearned Premiums | Other Policyholders' Funds | |||||||||||||||||||||||||||||||||||||||||||
| 2025: | |||||||||||||||||||||||||||||||||||||||||||||||
| Aflac Japan | $ | 5,302 | $ | 52,602 | $ | 1,245 | $ | 5,445 | |||||||||||||||||||||||||||||||||||||||
| Aflac U.S. | 3,732 | 11,281 | 97 | 0 | |||||||||||||||||||||||||||||||||||||||||||
| All other | 0 | 4,099 | (11) | 0 | |||||||||||||||||||||||||||||||||||||||||||
| Intercompany eliminations | 0 | (5,167) | (8) | 0 | |||||||||||||||||||||||||||||||||||||||||||
| Total | $ | 9,034 | $ | 62,815 | $ | 1,323 | $ | 5,445 | |||||||||||||||||||||||||||||||||||||||
| 2024: | |||||||||||||||||||||||||||||||||||||||||||||||
| Aflac Japan | $ | 5,102 | $ | 60,890 | $ | 1,199 | $ | 5,460 | |||||||||||||||||||||||||||||||||||||||
| Aflac U.S. | 3,656 | 10,960 | 103 | 0 | |||||||||||||||||||||||||||||||||||||||||||
| All other | 0 | 4,817 | 22 | 0 | |||||||||||||||||||||||||||||||||||||||||||
| Intercompany eliminations | 0 | (5,905) | (38) | 0 | |||||||||||||||||||||||||||||||||||||||||||
| Total | $ | 8,758 | $ | 70,762 | $ | 1,286 | $ | 5,460 |
Segment amounts may not agree in total to the corresponding consolidated amounts due to rounding.
Years Ended December 31,
| (In millions) | Net Earned Premiums | Net Investment Income | Total Benefits and Claims, net | Amortization of Deferred Policy Acquisition Costs | Other Operating Expenses | Premiums Written | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2025: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aflac Japan | $ | 6,744 | $ | 2,854 | $ | 3,999 | $ | 323 | $ | 1,595 | $ | 7,820 | |||||||||||||||||||||||||||||||||||||||||||||||
| Aflac U.S. | 5,999 | 854 | 2,837 | 551 | 2,094 | 6,177 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| All other | 805 | 368 | 458 | 0 | 775 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | $ | 13,548 | $ | 4,076 | $ | 7,293 | $ | 874 | $ | 4,464 | $ | 13,997 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2024: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aflac Japan | $ | 6,930 | $ | 3,032 | $ | 4,317 | $ | 321 | $ | 1,527 | $ | 7,866 | |||||||||||||||||||||||||||||||||||||||||||||||
| Aflac U.S. | 5,829 | 883 | 2,726 | 530 | 2,064 | 5,905 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| All other | 681 | 201 | 407 | 0 | 618 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | $ | 13,440 | $ | 4,116 | $ | 7,450 | $ | 851 | $ | 4,209 | $ | 13,771 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2023: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aflac Japan | $ | 8,047 | $ | 3,033 | $ | 5,313 | $ | 326 | $ | 1,790 | $ | 8,571 | |||||||||||||||||||||||||||||||||||||||||||||||
| Aflac U.S. | 5,675 | 854 | 2,431 | 490 | 2,201 | 5,666 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| All other | 400 | (77) | 467 | 0 | 421 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | $ | 14,123 | $ | 3,811 | $ | 8,211 | $ | 816 | $ | 4,412 | $ | 14,237 |
Segment amounts may not agree in total to the corresponding consolidated amounts due to rounding.
See the accompanying Report of Independent Registered Public Accounting Firm.
SCHEDULE IV
REINSURANCE
Aflac Incorporated and Subsidiaries
Years Ended December 31,
| (In millions) | Gross Amount | Ceded to Other Companies | Assumed from Other companies | Net Amount | Percentage of Amount Assumed to Net | ||||||||||||||||||||||||||||||||||||||||||
| 2025: | |||||||||||||||||||||||||||||||||||||||||||||||
| Life insurance in force | $ | 245,615 | $ | 13,495 | $ | 17,867 | $ | 249,987 | 7 | % | |||||||||||||||||||||||||||||||||||||
| Premiums: | |||||||||||||||||||||||||||||||||||||||||||||||
| Health insurance | $ | 11,857 | $ | 316 | $ | 132 | $ | 11,673 | 1 | % | |||||||||||||||||||||||||||||||||||||
| Life insurance | 1,903 | 52 | 24 | 1,875 | 1 | ||||||||||||||||||||||||||||||||||||||||||
| Total earned premiums | $ | 13,760 | $ | 368 | $ | 156 | $ | 13,548 | 1 | % | |||||||||||||||||||||||||||||||||||||
| 2024: | |||||||||||||||||||||||||||||||||||||||||||||||
| Life insurance in force | $ | 187,553 | $ | 13,481 | $ | 21,192 | $ | 195,264 | 11 | % | |||||||||||||||||||||||||||||||||||||
| Premiums: | |||||||||||||||||||||||||||||||||||||||||||||||
| Health insurance | $ | 11,784 | $ | 233 | $ | 135 | $ | 11,686 | 1 | % | |||||||||||||||||||||||||||||||||||||
| Life insurance | 1,778 | 51 | 27 | 1,754 | 2 | ||||||||||||||||||||||||||||||||||||||||||
| Total earned premiums | $ | 13,562 | $ | 284 | $ | 162 | $ | 13,440 | 1 | % | |||||||||||||||||||||||||||||||||||||
| 2023: | |||||||||||||||||||||||||||||||||||||||||||||||
| Life insurance in force | $ | 163,601 | $ | 15,592 | $ | 28,716 | $ | 176,725 | 16 | % | |||||||||||||||||||||||||||||||||||||
| Premiums: | |||||||||||||||||||||||||||||||||||||||||||||||
| Health insurance | $ | 12,335 | $ | 352 | $ | 167 | $ | 12,150 | 1 | % | |||||||||||||||||||||||||||||||||||||
| Life insurance | 1,983 | 52 | 42 | 1,973 | 2 | ||||||||||||||||||||||||||||||||||||||||||
| Total earned premiums | $ | 14,318 | $ | 404 | $ | 209 | $ | 14,123 | 1 | % |
Premiums by type may not agree in total to the corresponding consolidated amounts due to rounding.
See the accompanying Report of Independent Registered Public Accounting Firm.
Previous: Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES Proposal 3 Ratification of Auditors; and Audit and Risk Committee · Next: Item 16. FORM 10-K SUMMARY